Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Molecular Cancer|June 3, 2010
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeuticsCamilla Krakstad, Martha ChekenyaAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
PI3K pathway in gynecologic malignanciesHelga B Salvesen, Henrica Maria Werner, Camilla KrakstadJournal of Leukocyte Biology|June 5, 2004
cAMP protects neutrophils against TNF-alpha-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac)Camilla Krakstad, Anne Elisabeth Christensen, Stein Ove DøskelandPlos One|March 21, 2023
PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysisHanna K Bredin, Camilla Krakstad, Erling A HoivikFEBS Letters|June 28, 2003
cAMP effector mechanisms. Novel twists for an 'old' signaling systemReidun Kopperud, Camilla Krakstad, Frode Selheim, et al.Current Topics in Medicinal Chemistry|April 26, 2011
The cAMP-dependent protein kinase pathway as therapeutic target: possibilities and pitfallsRune Kleppe, Camilla Krakstad, Frode Selheim, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2025
Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [<sup>18</sup>F]FDG PET primary tumor radiomicsKristine Eldevik Fasmer, Ankush Gulati, Sunniva Lindås, et al.Pathology, Research and Practice|August 16, 2014
Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervixMari Kyllesø Halle, Camilla Krakstad, Hilde Engerud, et al.Cancers|December 1, 2019
Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted TherapyHeidi Espedal, Tina Fonnes, Kristine E Fasmer, et al.Biochemical and Biophysical Research Communications|July 16, 2013
Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood plateletsLars Herfindal, Gyrid Nygaard, Reidun Kopperud, et al.Pageof 15